Illumina: Pay

Illumina paid its 5 named executives $25.8M in total in FY2025 (Jan). CEO Jacob Thaysen was paid $11.0M of that.

Pay$100 in the stock at the end of FY22 → $38
CEO pay is from each proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Pay of each named executive

Jacob ThaysenChief Executive Officer
FY2025 (Jan)
FY2024 (Jan)
FY2023 (Jan)
3 years
Everett CunninghamFormer Chief Commercial Officer
FY2025 (Jan)
FY2024 (Jan)
2 years
Ankur DhingraChief Financial Officer
FY2025 (Jan)
FY2024 (Jan)
2 years
Steve BarnardChief Technology Officer
FY2025 (Jan)
FY2024 (Jan)
2 years
Kevin PegelsChief of Global Operations
FY2025 (Jan)
FY2024 (Jan)
2 years

CEO pay against the pay peers

In FY2025 (Jan), the median CEO pay of the 11 peers with pay on file was $14.7M. The CEO of Illumina was paid $11.0M, 25% below the median.

  1. 1Iqvia Holdings
  2. 2Intuitive Surgical
  3. 3Align Technology
  4. 4Edwards Lifesciences
  5. 5Cooper Companies
  6. 6Resmed
  7. 7Revvity
  8. 8Agilent Technologies
  9. 9Illumina
  10. 10Regeneron Pharmaceuticals
  11. 11West Pharmaceutical Services
  12. 12Mettler Toledo International Inc/
  13. 13AvantorNot disclosed
  14. 14Bio-Rad Laboratories, Inc.Not disclosed
  15. 15BioMarin PharmaceuticalNot disclosed
  16. 16BiogenNot disclosed
  17. 17BrukerNot disclosed
  18. 18DexcomNot disclosed
  19. 19Exact SciencesNot disclosed
  20. 20Hologic, Inc.Not disclosed
  21. 21IDEXX Laboratories, Inc.Not disclosed
  22. 22Jazz Pharmaceuticals plcNot disclosed
  23. 23Vertex Pharmaceuticals, Inc.Not disclosed
  24. 24Waters CorporationNot disclosed

Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.